Moderna says new-generation COVID vaccine more effective than Spikevax for adults 18 and over
Adults aged 18 and older enjoyed higher efficacy in a late-stage trial of Moderna’s next-gen vaccine than the original one.
Adults aged 18 and older enjoyed higher efficacy in a late-stage trial of Moderna’s next-gen vaccine than the original one.
